Stability of oxaliplatin in infusion bags containing 5% dextrose injection

被引:10
|
作者
Andre, Pascal
Cisternino, Salvatore
Roy, Anne-Lise
Chiadmi, Fouad
Schlatter, Joel
Agranat, Pascal
Fain, Olivier
Fontan, Jean-Eudes
机构
[1] Univ Hosp Jean Verdier, Dept Pharm Toxicol, F-93143 Bondy, France
[2] Univ Paris 06, Organ Chem Lab, Paris, France
关键词
antineoplastic agents; color concentration; containers; contamination; dextrose; diluents; hydrogen ion concentration; injections; oxaliplatin; photodecomposition; polyolefin; precipitation; stability; storage; temperature;
D O I
10.2146/ajhp060369
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Purpose. The stability of oxaliplatin in infusion bags containing 5% dextrose injection was studied. Methods. Solutions of oxaliplatin 0.7 mg/mL were prepared in polyolefin infusion bags containing 5% dextrose injection and stored at 3-7 degrees C in a lightproof bag, at 20-24 degrees C with continuous exposure to artificial light, and at 20-24 degrees C with continuous exposure to fluorescent light in a lightproof bag. Samples were analyzed at 1, 2, 3, 4, 5, 7, 14, and 30 days and assayed in duplicate. Stability was measured using a stability-indicating high-performance liquid chromatographic method. Samples were also examined for changes in color and pH and for the presence of particulate matter. Results. All samples retained over 90% of their initial concentration over the study period. No color changes or visible precipitation was observed, and the pH of all samples remained stable. Neither temperature nor artificial light had any significant effect on the stability of oxaliplatin. Conclusion. Oxaliplatin 0.7 mg/mL in infusion bags containing 5% dextrose injection was chemically stable for at least 30 days at both 3-7 degrees C and 20-24 degrees C without regard to light exposure.
引用
收藏
页码:1950 / 1954
页数:5
相关论文
共 50 条
  • [21] Stability of alemtuzumab in infusion-bags
    Kupfer, M.
    Scriba, G.
    Hartmann, M.
    PHARMAZIE, 2009, 64 (09): : 622 - 623
  • [22] STABILITY OF PROCAINAMIDE HYDROCHLORIDE IN NEUTRALIZED 5-PERCENT DEXTROSE INJECTION
    RAYMOND, GG
    REED, MT
    TEAGARDEN, JR
    STORY, K
    GEBERBAUER, CW
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1988, 45 (12): : 2513 - 2517
  • [23] STABILITY OF FLUMAZENIL WITH SELECTED DRUGS IN 5-PERCENT DEXTROSE INJECTION
    OLSEN, KM
    GURLEY, BJ
    DAVIS, GA
    CHRISTENSEN, R
    MONAGHAN, MS
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1993, 50 (09): : 1907 - 1912
  • [24] Stability of voriconazole injection in 0.9% sodium chloride and 5% dextrose injections
    Sahraoui, Laila
    Chiadmi, Fouad
    Schlatter, Joel
    Toledano, Audrey
    Cisternino, Salvatore
    Fontan, Jean-Eudes
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2006, 63 (15) : 1423 - 1426
  • [25] Stability of dexmedetomidine in polyvinyl chloride bags containing 0.9% sodium chloride injection
    Preslaski, Candice R.
    Mueller, Scott W.
    Wempe, Michael F.
    MacLaren, Robert
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2013, 70 (15) : 1336 - 1341
  • [26] Long term stability of voriconazole 4 mg/mL in dextrose 5% polyvinyl bags at 4°C
    Hecq, Jean-Daniel
    Gillet, Patricia
    Wolf, Cedric
    Vanbeckbergen, Danielle
    Jamart, Jacques
    Galanti, Laurence
    PHARMACY WORLD & SCIENCE, 2007, 29 (05): : 466 - 466
  • [27] Stability and compatibility of anakinra with ceftriaxone sodium injection in 0.9% sodium chloride or 5% dextrose injection
    Nahata, MC
    Morosco, RS
    Sabados, BK
    Weber, TR
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 1997, 22 (03) : 167 - 169
  • [28] Stability of Doripenem in Vitro in Representative Infusion Solutions and Infusion Bags
    Psathas, Petros A.
    Kuzmission, Andrew
    Ikeda, Kaori
    Yasuo, Shiho
    CLINICAL THERAPEUTICS, 2008, 30 (11) : 2075 - 2087
  • [29] STABILITY OF CYCLOSPORINE WITH MAGNESIUM-SULFATE IN 5-PERCENT DEXTROSE INJECTION
    NIEFORTH, KA
    SHEA, BF
    SOUNEY, PF
    SCAVONE, JM
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1993, 50 (03): : 470 - 472
  • [30] Stability of thiotepa (lyophilized) in 5% dextrose injection at 4 and 23 degrees C
    Xu, QYA
    Trissel, LA
    Zhang, YP
    Martinez, JF
    Gilbert, DL
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1996, 53 (22) : 2728 - 2730